Health care organizations are using artificial intelligence (AI)—which the U.S. Food and Drug Administration defines as “the science and engineering of making intelligent machines”—for a growing range ...

Each year, billions of dollars in improper payments are disbursed throughout states as a result of unemployment insurance (UI) fraud and overpayments. To address this problem, New Mexico’s Department ...

Nearly 300,000 people are held in state and federal prisons in the United States for drug-law violations, up from less than 25,000 in 1980. 1 These offenders served more time than in the past: Those ...

What problem is this policy meant to address? Medicare Part D plans (PDPs) are required to cover at least two drugs in each therapeutic class, defined as a group of drugs used to treat the same ...

The U.S. Food and Drug Administration’s Guidance for Industry #213 1 —a policy designed to ensure the judicious use of antibiotics that are medically important to humans in the production of food ...

This video is hosted by YouTube. In order to view it, you must consent to the use of “Marketing Cookies” by updating your preferences in the Cookie Settings link below. View on YouTube This video is ...

Editor's note: This report examines potential strategies that can be implemented on farms and feedlots to reduce the risk of human illnesses caused by pathogens in meat and poultry. A separate report ...

The Results First Clearinghouse Database is an online resource that brings together information on the effectiveness of social policy programs from nine national clearinghouses. It applies ...

Note: This issue brief has been updated with new data. Click here to see the latest version of “Federal Spending in the States.” The federal government spent $3.1 trillion in the states during its ...

In November 2013, French Polynesia’s government committed to protecting at least 20 percent of the French territory’s waters by 2020. More than 50 local organizations voiced support for this goal at a ...

Pharmaceutical compounding is the creation of medications for patients whose clinical needs cannot be met by commercially available products approved by the Food and Drug Administration. For example, ...

What problem is this policy meant to address? Biological products, or biologics, are drugs made up of proteins or other materials derived from living cells through a complex manufacturing process.